Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.

@article{Eckel2009ImagingOP,
  title={Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.},
  author={Florian Eckel and Ken Herrmann and Stefan Schmidt and Claudia Hillerer and Hinrich A. Wieder and B Krause and Tibor Schuster and Rupert Langer and Hans-J{\"u}rgen Wester and Roland M Schmid and Markus Schwaiger and Andreas K. Buck},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2009},
  volume={50 9},
  pages={
          1441-7
        }
}
  • Florian Eckel, Ken Herrmann, +9 authors Andreas K. Buck
  • Published in
    Journal of nuclear medicine…
    2009
  • Medicine
  • UNLABELLED We determined the ability of PET with the thymidine analog 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) to detect hepatocellular carcinoma (HCC). METHODS In this pilot study, (18)F-FLT PET was performed in 18 untreated patients with clinically suspected HCC. Routine diagnostic procedures included ultrasound, MRI, or contrast-enhanced spiral CT of the upper gastrointestinal tract in all patients. At 45-60 min after the intravenous injection of approximately 270-340 MBq of (18)F-FLT… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 27 CITATIONS